Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.70 |
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30279513 | 0.87 | MEN1 (0.59) | LMNAMAPTMEN1KMT2AKDM4E | |
| SCHEMBL5559041 | 0.87 | MEN1 (0.59) | LMNAMAPTMEN1KMT2AKDM4E | |
| SCHEMBL13727299 | 0.83 | LMNA (1.00) | LMNAMAPTALOX15MEN1KMT2A | |
| SCHEMBL6139458 | 0.82 | KMT2A (0.72) | LMNAMAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7758530 | 0.82 | GAA (0.57) | LMNAMEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL8947821 | 0.82 | MEN1 (0.61) | LMNAMEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL7758478 | 0.80 | LMNA (0.61) | LMNAMAPTALOX15MEN1KMT2A | |
| SCHEMBL8063625 | 0.80 | CYP1A2 (0.51) | LMNAMEN1KMT2ASMN1; SMN2KDM4E | |
| Hydrochloric Acid SCHEMBL8637764 | 0.79 | LMNA (0.60) | LMNAMAPTALOX15MEN1KMT2A | |
| SCHEMBL6160982 | 0.79 | LMNA (0.70) | LMNAMAPTALOX15MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1277746-B1 | N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions thereof | SERVIER LAB (FR) | 2005-05-11 | — | — | EP | disclosed |
| US-6686360-B2 | ANTIISCHEMIC AGENTS | LES LABORATOIRES SERVIER (FR) | 2004-02-03 | — | — | US | disclosed |
| US-20030158207-A1 | N-benzylpiperazine compounds | LES LABORATOIRES SERVIER (FR) | 2003-08-21 | — | — | US | disclosed |
| EP-1277746-A2 | N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions thereof | Les Laboratoires Servier (FR) | 2003-01-22 | — | — | EP | disclosed |
| WO-1997044334-A2 | NOVEL PIPERAZINE OR HOMOPIPERAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND A PROCESS FOR THEIR PREPARATION | EGIS Gyógyszergyár Rt. (HU) | 1997-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158207-A1 | N-benzylpiperazine compounds | NPPA, BAD, GLS | LMNA 1289/4885MAPT 4736/4885ALOX15 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.